Navigation Links
Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Date:1/27/2011

EAST BRUNSWICK, N.J., Jan. 27, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it will grant, on January 31, 2011, a stock option to John H. Johnson pursuant to the NASDAQ inducement grant exception as a component of Mr. Johnson's employment compensation.  The inducement grant was approved by the Company's Board of Directors on January 23, 2011 and is being made as an inducement material to Mr. Johnson's acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). Savient previously announced that Mr. Johnson has been appointed Chief Executive Officer and a member of the Company's Board of Directors, effective January 31, 2011.  

The stock option approved by the Company's Board of Directors is for the purchase of 250,000 shares of the Company's common stock with an exercise price equal to the closing price of the Company's common stock on January 31, 2011.  The option will have a ten-year term and will vest and become exercisable upon the satisfaction of the performance conditions to be agreed upon by Mr. Johnson and the Company's Board of Directors.  In the event of a termination by the Company without "cause" (as such term is defined in the employment agreement between the Company and Mr. Johnson) or by Mr. Johnson for "good reason" (as such term is defined in the employment agreement), the stock option shall (i) cease to be exercisable and shall cease to continue vesting, but shall not terminate, on the 90th day following the effective date of Mr. Johnson's termination, (ii) become again exercisable from and after consummation of any "change of control" (as such term is defined in the employment agreement) of the Company that is consummated on or prior to the one-year anniversary of the effective date of Mr. Johnson's termination and (iii) terminate if a change of control of the Comp
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Savient Provides Update on KRYSTEXXA(TM) BLA Resubmission Activities
8. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
9. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2009 Financial Results
10. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
11. Savient Pharmaceuticals To Hold First Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
(Date:12/24/2014)... 23, 2014 Tianyin Pharmaceutical Co., Inc. ... in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... announced that the Company achieved the Public Notice ... (GMP) certificate of TPI,s Qionglai Facility (QLF) from ... public notice period is a significant procedure of ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... PASADENA, Calif., April 23, 2012 The herpes zoster vaccine, ... well tolerated according to a Vaccine Safety Datalink study of ... Medicine. More than 1 million people develop ... painful contagious rash caused by the dormant chickenpox virus which ...
... /PRNewswire-iReach/ -- Global Information Inc. is pleased to ... healthcare conferences around the globe: World ... European healthcare systems may be diverse, but the all ... in common by health systems across the entire world, ...
Cached Medicine Technology:Shingles Vaccine is Safe, According to New Study 2Shingles Vaccine is Safe, According to New Study 3Shingles Vaccine is Safe, According to New Study 4Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc. 2Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc. 3
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... Los Angeles, CA (PRWEB) December 25, 2014 ... Blaise Dolcemaschio was created in honor of a true ... premiere at two film festivals including the 24 hours of ... Film Festival in Bangladesh. , Actress, screenwriter and ... and helped produce this film together with her husband, ...
(Date:12/25/2014)... FL (PRWEB) December 25, 2014 When head ... find themselves in a frenzy to get rid of it ... But families in Coral Gables now have the solution right ... second salon clinic location, Lice Troopers provides full spectrum head ... the Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut ...
(Date:12/25/2014)... Overeating is common during the holidays, but there are strategies ... "Don,t arrive at a party hungry. It may seem ... attending a party, but deprivation leads to hunger, and hunger ... Hospital in Mount Kisco, N.Y., said in a hospital news ... and even to have a snack before attending a party ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... ) continue to move forward in a number of ... District of West Virginia, Bernstein Liebhard LLP reports. According ... Court is scheduled to convene a Joint Status Conference ... at 10:00 a.m. Parties have been directed to submit ...
Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... the Journal of American Society of Nephrology by The ... that lowering blood pressure protects stroke victims with Chronic ... the high risk of cardiovascular complications in people with ... for millions of people across the world. , According ...
... Tenn., Oct. 5 Emdeon Business Services,announced ... Delta Dental payers for,insurance eligibility and benefits ... vendor partners and through the Emdeon suite ... Provider Services,(DPS), Emdeon,s interactive web portal. Emdeon ...
... 5 Martek Biosciences,Corporation announced today that it has ... Farmacia, S.A. for the inclusion of,Martek,s arachidonic acid (ARA) ... the agreement, Alter Farmacia will purchase Martek,s ARA,for all ... in Spain and,Portugal. Headquartered in Spain, Alter Farmacia ...
... than many retired players, study finds , , FRIDAY, Oct. 5 (HealthDay ... York Jets football team capture Super Bowl III in 1969 -- ... seems to have followed the players well into their retirement. , ... just fine. , But the study authors were quick to add ...
... milestones including phase III development of ,GI-friendly, ... Horizon Therapeutics, Inc. is pleased to announce that ... executive officer, will ... including its recent completion of Series C financing, and ...
... Action Camera to Capture Exclusive Event Footage, ... of the,world,s leading designers and marketers of award-winning ... Love Hope,Strength Foundation as an official sponsor of ... 40 of the world,s top musicians and,mountaineers, Everest ...
Cached Medicine News:Health News:Double cardiovascular benefit for people with chronic kidney disease 2Health News:Emdeon Business Services Extends Market Leadership With New Dental Eligibility Payers 2Health News:Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia 2Health News:'69 New York Jets Continue Their Winning Ways 2Health News:'69 New York Jets Continue Their Winning Ways 3Health News:'69 New York Jets Continue Their Winning Ways 4Health News:'69 New York Jets Continue Their Winning Ways 5Health News:Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting 2Health News:Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest 2Health News:Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest 3
Standard Erlanger hip stem....
Porous foundation 480 series....
Cemented foundation 450 series....
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Medicine Products: